Accelerate Diagnostics
AXDX
C$0.04671
Share price
0.00%
Change (1 day)
-97.37%
Change (1 year)
Categories
Revenue for Accelerate Diagnostics (AXDX)
Revenue in 2024 (TTM): C$16.09 Million
According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM 
) is C$16.06 Million. an increase over the revenue in the year 2023 that were of C$15.99 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Accelerate Diagnostics from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | C$16.78 M | 4.95% |
| 2023 | C$15.99 M | -7.56% |
| 2022 | C$17.3 M | 15.24% |
| 2021 | C$15.01 M | 5.47% |
| 2020 | C$14.23 M | 17.23% |
| 2019 | C$12.14 M | 57.21% |
| 2018 | C$7.72 M | 47.11% |
| 2017 | C$5.25 M | 1488.17% |
| 2016 | C$0.33 M | 62.12% |
| 2015 | C$0.2 M | 44.03% |
| 2014 | C$0.14 M | 174.58% |
| 2013 | C$0.05 M | |
| 2011 | C$0.56 M | -81.04% |
| 2010 | C$2.95 M | 319.53% |
| 2009 | C$0.7 M | -38.4% |
| 2008 | C$1.14 M | 376.46% |
| 2007 | C$0.24 M | -2.74% |
| 2006 | C$0.24 M | -44.34% |
| 2005 | C$0.44 M | -15085.27% |
| 2004 | -C$0.01 Million | -100.44% |
| 2003 | C$0.67 M | -44.66% |
| 2002 | C$1.21 M | 46.26% |
| 2001 | C$0.82 M | -53.44% |
| 2000 | C$1.78 M | -49.93% |
| 1999 | C$3.55 M | -50% |
| 1998 | C$7.11 M | -14.67% |
| 1997 | C$8.33 M | 164.62% |
| 1996 | C$3.15 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | C$58.92 B | 366,612.26% | 🇺🇸 USA |
 PerkinElmer
PKI | C$4.61 B | 28,601.07% | 🇺🇸 USA |
 Becton Dickinson BDX | C$28.66 B | 178,280.92% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | C$3.49 B | 21,622.35% | 🇺🇸 USA |
 NanoString Technologies NSTG | C$0.22 B | 1,288.90% | 🇺🇸 USA |
 Bruker BRKR | C$4.73 B | 29,358.88% | 🇺🇸 USA |